Evaluation of Lassa antiviral compound ST-193 in a guinea pig model

Lassa virus (LASV), a member of the Arenaviridae family, causes a viral hemorrhagic fever endemic to West Africa, where as many as 300,000 infections occur per year. Presently, there are no FDA-approved LASV-specific vaccines or antiviral agents, although the antiviral drug ribavirin has shown some...

Descripción completa

Detalles Bibliográficos
Autores principales: Cashman, Kathleen A., Smith, Mark A., Twenhafel, Nancy A., Larson, Ryan A., Jones, Kevin F., Allen, Robert D., Dai, Dongcheng, Chinsangaram, Jarasvech, Bolken, Tove’ C., Hruby, Dennis E., Amberg, Sean M., Hensley, Lisa E., Guttieri, Mary C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. Published by Elsevier B.V. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319460/
https://www.ncbi.nlm.nih.gov/pubmed/21371508
http://dx.doi.org/10.1016/j.antiviral.2011.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319460/
https://www.ncbi.nlm.nih.gov/pubmed/21371508
http://dx.doi.org/10.1016/j.antiviral.2011.02.012

Ejemplares similares